| DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer C Mao, X Liu, Y Zhang, G Lei, Y Yan, H Lee, P Koppula, S Wu, L Zhuang, ... Nature 593 (7860), 586-590, 2021 | 895 | 2021 |
| Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA M Wang, C Mao, L Ouyang, Y Liu, W Lai, N Liu, Y Shi, L Chen, D Xiao, ... Cell Death & Differentiation 26 (11), 2329-2343, 2019 | 420 | 2019 |
| A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53 C Mao, X Wang, Y Liu, M Wang, B Yan, Y Jiang, Y Shi, Y Shen, X Liu, ... Cancer research 78 (13), 3484-3496, 2018 | 379 | 2018 |
| mTORC1 couples cyst (e) ine availability with GPX4 protein synthesis and ferroptosis regulation Y Zhang, RV Swanda, L Nie, X Liu, C Wang, H Lee, G Lei, C Mao, ... Nature communications 12 (1), 1-14, 2021 | 378 | 2021 |
| Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis X Liu, L Nie, Y Zhang, Y Yan, C Wang, M Colic, K Olszewski, A Horbath, ... Nature cell biology 25 (3), 404-414, 2023 | 329 | 2023 |
| EGLN1/c-Myc induced lymphoid-specific helicase inhibits ferroptosis through lipid metabolic gene expression changes Y Jiang, C Mao, R Yang, B Yan, Y Shi, X Liu, W Lai, Y Liu, X Wang, ... Theranostics 7 (13), 3293, 2017 | 223 | 2017 |
| Ferroptosis, radiotherapy, and combination therapeutic strategies G Lei, C Mao, Y Yan, L Zhuang, B Gan Protein & cell 12 (11), 836-857, 2021 | 208 | 2021 |
| Genome and transcriptome analysis of the fungal pathogen Fusarium oxysporum f. sp. cubense causing banana vascular wilt disease L Guo, L Han, L Yang, H Zeng, D Fan, Y Zhu, Y Feng, G Wang, C Peng, ... PLoS One 9 (4), e95543, 2014 | 192 | 2014 |
| A targetable CoQ-FSP1 axis drives ferroptosis-and radiation-resistance in KEAP1 inactive lung cancers P Koppula, G Lei, Y Zhang, Y Yan, C Mao, L Kondiparthi, J Shi, X Liu, ... Nature communications 13 (1), 2206, 2022 | 173 | 2022 |
| Emerging mechanisms and targeted therapy of ferroptosis in cancer H Wang, Y Cheng, C Mao, S Liu, D Xiao, J Huang, Y Tao Molecular Therapy 29 (7), 2185-2208, 2021 | 159 | 2021 |
| Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity G Lei, Y Zhang, T Hong, X Zhang, X Liu, C Mao, Y Yan, P Koppula, ... Oncogene 40 (20), 3533-3547, 2021 | 120 | 2021 |
| Chromatin remodeling factor LSH drives cancer progression by suppressing the activity of fumarate hydratase X He, B Yan, S Liu, J Jia, W Lai, X Xin, C Tang, D Luo, T Tan, Y Jiang, ... Cancer research 76 (19), 5743-5755, 2016 | 104 | 2016 |
| Chromatin remodeling factor LSH is upregulated by the LRP6-GSK3β-E2F1 axis linking reversely with survival in gliomas D Xiao, J Huang, Y Pan, H Li, C Fu, C Mao, Y Cheng, Y Shi, L Chen, ... Theranostics 7 (1), 132, 2017 | 63 | 2017 |
| Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation T Li, C Mao, X Wang, Y Shi, Y Tao Journal of Experimental & Clinical Cancer Research 39, 1-25, 2020 | 62 | 2020 |
| A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria S Wu, C Mao, L Kondiparthi, MV Poyurovsky, K Olszewski, B Gan Proceedings of the National Academy of Sciences 119 (26), e2121987119, 2022 | 59 | 2022 |
| The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH R Wang, Y Shi, L Chen, Y Jiang, C Mao, B Yan, S Liu, B Shan, Y Tao, ... Scientific reports 5 (1), 17826, 2015 | 59 | 2015 |
| Cancer progression is mediated by proline catabolism in non-small cell lung cancer Y Liu, C Mao, M Wang, N Liu, L Ouyang, S Liu, H Tang, Y Cao, S Liu, ... Oncogene 39 (11), 2358-2376, 2020 | 57 | 2020 |
| The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor L Ouyang, B Yan, Y Liu, C Mao, M Wang, N Liu, Z Wang, S Liu, Y Shi, ... Signal Transduction and Targeted Therapy 5 (1), 78, 2020 | 52 | 2020 |
| Nuclear EGFR-PKM2 axis induces cancer stem cell-like characteristics in irradiation-resistant cells Y Shi, N Liu, W Lai, B Yan, L Chen, S Liu, S Liu, X Wang, D Xiao, X Liu, ... Cancer Letters 422, 81-93, 2018 | 48 | 2018 |
| GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3–mediated deubiquitination of LSH R Yang, N Liu, L Chen, Y Jiang, Y Shi, C Mao, Y Liu, M Wang, W Lai, ... Oncogene 38 (46), 7133-7145, 2019 | 46 | 2019 |
